Biomarker out-licensing
Accelerating market adoption through strategic partnerships
At SphingoTec, we believe that the broad adoption of innovative diagnostics is best achieved through collaboration. To make our first-in-class biomarkers available to clinicians and patients worldwide, we partner with leading global IVD companies. Our portfolio is available for licensing to organizations seeking to enrich their immunoassay offerings and to develop biomarker-based diagnostics for clinical use on high-throughput and near-patient testing platforms.
Licensing enables partners to:
- Integrate SphingoTec’s biomarkers into their diagnostic platforms for laboratory or near-patient testing.
- Accelerate time-to-market with robust, ready-to-implement biomarkers supported by strong scientific and clinical evidence.
- Benefit from SphingoTec’s development expertise and established clinical networks.
Ready-to-scale solutions
We have developed a robust blueprint-shaped by strategic accomplishments-to minimize development uncertainties and accelerate market readiness for innovative biomarkers on third-party platforms.
Serviceliste
-
Robust scientific foundationListenelement Nr. 1
We have established a proven link between disease pathways and our biomarkers, backed by extensive scientific evidence and high analytical accuracy of the reference technologies.
-
Intellectual property securityListenelement Nr. 2
Our innovations are protected by strong patents, ensuring a competitive advantage in the market.
-
Proven clinical utilityListenelement Nr. 3
Our biomarkers are scientifically validated and address unmet clinical needs, with proven utility demonstrated by successful proof-of-concept in leading hospitals and routine clinical use.
-
Market-ready solution
Our assays are developed for clinical relevance and scalability, offering a robust blueprint for seamless integration into partner diagnostic pipelines—ideal for in-licensing by companies seeking innovative biomarker solutions.
-
Multidisciplinary expertise
Our team possesses deep expertise in critical care biomarkers, assay development, clinical implementation, and collaborations with leading academic and medical centers.
Reach out to us
Neuendorfstr. 15A
16761 Hennigsdorf, Germany
info@sphingotec.com